使用自动化Elecsys抗苗勒管激素检测在促性腺激素释放激素拮抗剂周期中预测卵巢反应
本研究为单中心回顾性观察性队列研究,纳入1248例接受卵巢刺激的女性,采用Elecsys AMH免疫分析法检测治疗前6个月内血清AMH。AMH与获卵数呈强正相关(Spearman rho=0.74,P<0.001),预测低反应和高反应的曲线下面积分别为0.85(95%CI 0.83-0.88)和0.89(95%CI 0.87-0.91),最佳cut-off分别为6.4 pmol/l(0.89 ng/ml)和14.2 pmol/l(1.99 ng/ml)。
要点
- 血清AMH与获卵数强正相关(Spearman rho=0.74,P<0.001)。
- 预测低反应AUC为0.85(95%CI 0.83-0.88),高反应AUC为0.89(95%CI 0.87-0.91)。
- 预测低和高反应的最佳AMH cut-off分别为6.4 pmol/l(0.89 ng/ml)和14.2 pmol/l(1.99 ng/ml)。
核心结论
- 在GnRH拮抗剂周期中,卵巢刺激前单次测定血清AMH可高精度预测卵巢反应和获卵数。
研究设计与样本
- 单中心、回顾性、观察性队列研究,纳入1248例接受卵巢刺激的女性。
- 血清AMH采用Elecsys AMH免疫分析法基于治疗前6个月内一次血样测定。
- 刺激按GnRH拮抗剂方案进行,根据获卵数分为低反应(0-3)、次优反应(4-9)、最佳反应(10-15)和高反应(>15)四组。
主要发现
- AMH与获卵数呈强正相关(Spearman rho=0.74,P<0.001)。
- 预测低反应的AUC为0.85(95%CI 0.83-0.88),预测高反应的AUC为0.89(95%CI 0.87-0.91)。
- 预测低和高反应的最佳血清AMH cut-off分别为6.4 pmol/l(0.89 ng/ml)和14.2 pmol/l(1.99 ng/ml)。
- 多变量回归分析显示,卵巢反应变异的47%(R2=0.470)可归因于AMH单独,加入年龄、体重和促性腺激素总剂量后增至50.9%(R2=0.509)。
关键数值与推荐
- 卵巢反应分类基于获卵数:低反应0-3、次优反应4-9、最佳反应10-15、高反应>15。
- 预测低反应的最佳AMH cut-off为6.4 pmol/l(0.89 ng/ml),预测高反应的最佳AMH cut-off为14.2 pmol/l(1.99 ng/ml)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the capability of serum anti-Müllerian hormone (AMH) measured using the automated Elecsys® AMH immunoassay to (Roche Diagnostics International Ltd) determine ovarian response after fertility treatment? DESIGN: Single-centre, retrospective, observational, cohort study including women undergoing ovarian stimulation. Serum AMH concentrations were determined using the Elecsys AMH immunoassay based on one blood sample drawn 6 months or less before treatment. Stimulation was conducted in accordance with a gonadotrophin-releasing hormone (GnRH) antagonist protocol. Patients were divided into four ovarian response categories based on their oocyte yield: low (0-3), suboptimal (4-9), optimal (10-15) and high (>15). Areas under the curve were calculated for each ovarian response group. RESULTS: Overall, 1248 patients were enrolled. The AMH concentration had a strong positive correlation with oocyte yield (Spearman's rho = 0.74, P < 0.001). Areas under the curve (95% CI) for AMH predicting ovarian response were 0.85 (0.83 to 0.88) for low and 0.89 (0.87 to 0.91) for high response. Optimal serum AMH cut-offs for predicting a low and high response using the Elecsys AMH immunoassay were 6.4 pmol/l (0.89 ng/ml) and 14.2 pmol/l (1.99 ng/ml), respectively. Multivariable regression analysis showed that 47% (R2 = 0.470) of variation in ovarian response could be attributed to AMH alone, increasing to 50.9% (R2 = 0.509) with the addition of age, body weight, and total dose of gonadotrophin. CONCLUSION: Ovarian response and oocyte yield after stimulation in a GnRH antagonist cycle can be predicted with high accuracy using a single determination of serum AMH before ovarian stimulation.
引用
- Bosch E, Labarta E, Zuzuarregui J, et al. Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles. Reprod Biomed Online. 2022. PMID: 36522281. doi:10.1016/j.rbmo.2022.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。